Molecular typing is based on molecular genetic testing and is not still routinely out there. Molecular subtypes and immunohistochemical surrogate markers on the tumors (HR, HER2, triple adverse) correlate in about 70%. The differentiation of luminal A and B subtypes by HR position and proliferation markers like Ki-sixty seven https://betteo530jsz7.nytechwiki.com/user